CompletedPhase 3

Fluticasone Nasal Spray Patient Preference Study

United States127 participantsStarted 2006-12-01

Plain-language summary

The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * allergic rhinitis * literate Exclusion Criteria: * clinical significant uncontrolled disease * Use of intranasal corticosteroids (\<4 weeks of FP \[branded or generic\],\<4 week exposure to FF, \<4 weeks use of other INS) * Use of intranasal medications \<1 week * Use of meds that significantly inhibit CYP4503A4 * Use of perfume or oral rinse on study day * Allergy/intolerance to INS, antihistamines, or excipients * Positive pregnancy test or female who is breastfeeding * Affiliation with investigational site

What they're measuring

Overall Participants Preference for Nasal Spray Based on Selected Product Attributes at the End of Crossover Dosing

Timeframe: Day 1

Trial details

NCT IDNCT00398476

SponsorGlaxoSmithKline

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-12-04

Results submitted2017-06-08

View on ClinicalTrials.gov More Rhinitis, Allergic, Perennial trials